Cargando…
Correlation between Serum Zinc Levels and Levodopa in Parkinson’s Disease
Long-term intake of potential zinc-chelating drugs may cause zinc deficiency. We postulated that zinc deficiency in Parkinson’s disease (PD) patients was related to the intake of drugs such as levodopa. We investigated the relationship between zinc levels and levodopa administration period, dosage,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621473/ https://www.ncbi.nlm.nih.gov/pubmed/34836369 http://dx.doi.org/10.3390/nu13114114 |
_version_ | 1784605466581532672 |
---|---|
author | Matsuyama, Hirofumi Matsuura, Keita Ishikawa, Hidehiro Hirata, Yoshinori Kato, Natsuko Niwa, Atsushi Narita, Yugo Tomimoto, Hidekazu |
author_facet | Matsuyama, Hirofumi Matsuura, Keita Ishikawa, Hidehiro Hirata, Yoshinori Kato, Natsuko Niwa, Atsushi Narita, Yugo Tomimoto, Hidekazu |
author_sort | Matsuyama, Hirofumi |
collection | PubMed |
description | Long-term intake of potential zinc-chelating drugs may cause zinc deficiency. We postulated that zinc deficiency in Parkinson’s disease (PD) patients was related to the intake of drugs such as levodopa. We investigated the relationship between zinc levels and levodopa administration period, dosage, and symptoms of zinc deficiency in PD patients. We measured serum zinc levels and analyzed correlations between serum zinc levels, the levodopa oral administration period, dosage, dosing frequency, and zinc deficiency symptoms including taste disorders. Data analyses were performed using Spearman’s rank correlation coefficient. The mean serum zinc level was 60.5 ± 11.6 μg/dL. The mean administration period for levodopa was 8.0 ± 5.5 years, mean administration frequency 3.4 ± 0.9 times/d, and mean administration dose 420.6 ± 237.1 mg/d. Negative correlations between zinc levels and levodopa dosage and dosing frequency were found. Multiple regression analysis showed a significant correlation with the frequency of levodopa (β = −0.360, p = 0.007). No significant change in clinical symptoms was observed after zinc administration, but anxiety tended to improve. Our results indicated that frequent levodopa administration strongly influenced serum zinc levels which may have alleviating effects on psychiatric symptoms; therefore, preventing zinc deficiency can be important during PD treatment. |
format | Online Article Text |
id | pubmed-8621473 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86214732021-11-27 Correlation between Serum Zinc Levels and Levodopa in Parkinson’s Disease Matsuyama, Hirofumi Matsuura, Keita Ishikawa, Hidehiro Hirata, Yoshinori Kato, Natsuko Niwa, Atsushi Narita, Yugo Tomimoto, Hidekazu Nutrients Article Long-term intake of potential zinc-chelating drugs may cause zinc deficiency. We postulated that zinc deficiency in Parkinson’s disease (PD) patients was related to the intake of drugs such as levodopa. We investigated the relationship between zinc levels and levodopa administration period, dosage, and symptoms of zinc deficiency in PD patients. We measured serum zinc levels and analyzed correlations between serum zinc levels, the levodopa oral administration period, dosage, dosing frequency, and zinc deficiency symptoms including taste disorders. Data analyses were performed using Spearman’s rank correlation coefficient. The mean serum zinc level was 60.5 ± 11.6 μg/dL. The mean administration period for levodopa was 8.0 ± 5.5 years, mean administration frequency 3.4 ± 0.9 times/d, and mean administration dose 420.6 ± 237.1 mg/d. Negative correlations between zinc levels and levodopa dosage and dosing frequency were found. Multiple regression analysis showed a significant correlation with the frequency of levodopa (β = −0.360, p = 0.007). No significant change in clinical symptoms was observed after zinc administration, but anxiety tended to improve. Our results indicated that frequent levodopa administration strongly influenced serum zinc levels which may have alleviating effects on psychiatric symptoms; therefore, preventing zinc deficiency can be important during PD treatment. MDPI 2021-11-17 /pmc/articles/PMC8621473/ /pubmed/34836369 http://dx.doi.org/10.3390/nu13114114 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Matsuyama, Hirofumi Matsuura, Keita Ishikawa, Hidehiro Hirata, Yoshinori Kato, Natsuko Niwa, Atsushi Narita, Yugo Tomimoto, Hidekazu Correlation between Serum Zinc Levels and Levodopa in Parkinson’s Disease |
title | Correlation between Serum Zinc Levels and Levodopa in Parkinson’s Disease |
title_full | Correlation between Serum Zinc Levels and Levodopa in Parkinson’s Disease |
title_fullStr | Correlation between Serum Zinc Levels and Levodopa in Parkinson’s Disease |
title_full_unstemmed | Correlation between Serum Zinc Levels and Levodopa in Parkinson’s Disease |
title_short | Correlation between Serum Zinc Levels and Levodopa in Parkinson’s Disease |
title_sort | correlation between serum zinc levels and levodopa in parkinson’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621473/ https://www.ncbi.nlm.nih.gov/pubmed/34836369 http://dx.doi.org/10.3390/nu13114114 |
work_keys_str_mv | AT matsuyamahirofumi correlationbetweenserumzinclevelsandlevodopainparkinsonsdisease AT matsuurakeita correlationbetweenserumzinclevelsandlevodopainparkinsonsdisease AT ishikawahidehiro correlationbetweenserumzinclevelsandlevodopainparkinsonsdisease AT hiratayoshinori correlationbetweenserumzinclevelsandlevodopainparkinsonsdisease AT katonatsuko correlationbetweenserumzinclevelsandlevodopainparkinsonsdisease AT niwaatsushi correlationbetweenserumzinclevelsandlevodopainparkinsonsdisease AT naritayugo correlationbetweenserumzinclevelsandlevodopainparkinsonsdisease AT tomimotohidekazu correlationbetweenserumzinclevelsandlevodopainparkinsonsdisease |